XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Considerations (Tables)
3 Months Ended
Sep. 30, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Schedule of fair value on a recurring basis

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

​

Fair Value Measurements at September 30, 2022

​

    

Fair Value at September 30, 

    

​

    

​

    

​

​

​

2022

 

(Level 1)

 

(Level 2)

 

(Level 3)

​

​

(In thousands)

Assets:

 

​

​

 

​

​

​

​

​

​

​

​

Cash and cash equivalents

​

$

23,811

​

$

23,811

​

$

—

​

$

—

Total

​

$

23,811

 

$

23,811

 

$

—

​

$

—

Liabilities:

​

​

​

​

​

​

​

​

​

​

​

​

Contingent consideration

 

$

423

 

$

—

 

$

—

 

$

423

CVR liability

 

​

706

 

​

—

 

​

—

 

​

706

Total

​

$

1,129

 

$

—

 

$

—

​

$

1,129

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

​

Fair Value Measurements at June 30, 2022

​

    

Fair Value at June 30, 

    

​

    

​

    

​

​

​

2022

 

(Level 1)

 

(Level 2)

 

(Level 3)

​

 

(In thousands)

Assets:

​

​

​

​

​

​

​

​

​

​

​

​

Cash and cash equivalents

​

$

19,360

​

$

19,360

​

$

—

​

$

—

Total

​

$

19,360

 

$

19,360

 

$

—

​

$

—

Liabilities:

​

​

​

​

​

​

​

​

​

​

​

​

Contingent consideration

​

$

396

 

$

—

 

$

—

 

$

396

CVR liability

​

​

578

 

​

—

 

​

—

 

​

578

Total

​

$

974

 

$

—

 

$

—

​

$

974

​

Schedule of changes in Level 3 inputs

​

​

​

​

​

​

​

​

​

​

​

​

​

    

CVR

    

Contingent

​

​

Fixed Payment

​

​

​

Liability

​

Consideration

​

​

Arrangement

​

​

​

(In thousands)

Balance as of June 30, 2022

 

$

578

​

$

396

​

$

13,051

​

Included in earnings

 

​

128

​

​

27

​

​

446

​

Purchases, issues, sales and settlements:

 

 

​

​

​

​

​

​

​

​

Settlements

 

 

—

​

 

—

​

 

(1,025)

​

Balance as of September 30, 2022

 

$

706

​

$

423

​

$

12,472

​

​

Contingent Value Rights  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Schedule of significant assumptions used in valuation

​

​

​

​

​

​

​

September 30, 

​

    

2022

Leveraged Beta

 

0.84

​

Market risk premium

​

6.22

%

Risk-free interest rate

​

4.09

%

Discount

​

21.50

%

Company specific discount

 

10.00

%

​

Derivative Financial Instruments, Liabilities  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Schedule of significant assumptions used in valuation

​

​

​

​

​

​

​

August 9,

​

    

2022

Expected volatility

 

62.71

%

Equivalent term (years)

​

5.00

​

Risk-free rate

​

2.97

%

Dividend yield

​

0.00

%

​